In response to recent U.S. Supreme Court decisions addressing utility patent subject matter eligibility under 35 U.S.C. § 101, the U.S. Patent & Trademark Office issued new guidance and training materials for patent examiners tasked with determining eligibility of machine, composition, manufacture and process claims "involving laws of nature, natural phenomena, and natural products." The USPTO published the guidance memorandum and training slides, requesting public comment and suggestions for future examiner training.
The USPTO explained that the new guidance replaces current guidance for process claims involving laws of nature, based on Mayo Collaborative Services v. Prometheus Laboratories, Inc., 566 U.S. __, 132 S. Ct. 1289, 101 USPQ2d 1961 (2012), and product claims reciting nucleic acids, based on Pathology v. Myriad Genetics, Inc., 569 U.S. __, 133 S. Ct. 2107, 2116, 106 USPQ2d 1972 (2013). In the USPTO's view, Myriad impacted the Supreme Court's stance on the inability to patent naturally occurring things by:
rel[ying] on [Diamond v. Chakrabarty, 447 U.S. 303 (1980)] as “central” to the eligibility inquiry, and re-affirm[ing] the Office’s reliance on Chakrabarty’s criterion for eligibility of natural products (i.e., whether the claimed product is a non-naturally occurring product of human ingenuity that is markedly different from naturally occurring products). Id. at 2116-17. Myriad also clarified that not every change to a product will result in a marked difference, and that the mere recitation of particular words (e.g., “isolated”) in the claims does not automatically confer eligibility. Id. at 2119.
The new guidance does not change the analysis of claims reciting abstract ideas. The USPTO will continue to use existing guidance for such claims, as the law in this area is "unsettled" and the Supreme Court will consider the abstract idea judicial exception this year. A Quick Reference Sheet summarizing the new guidance also is available. Additional information can be found here and comments can be sent to the USPTO via email to: email@example.com
About MVA Litigation Blog
Companies are operating in an increasingly globalized and regulated business environment, facing ever-changing and complicated litigation and regulatory challenges. We provide cutting-edge information regarding developments in federal, North Carolina State, and international litigation, as well as in arbitration, regulatory enforcement, and related business practices.
MVA Litigation Blog Updates
- As States Begin to Ease COVID-19 Restrictions, How Are Businesses Faring in Business Interruption Coverage Disputes?
- Is There a Fix for COVID Business Interruption and Event Cancellations Losses on the Horizon?
- Pandemic Risk Insurance Act of 2020 Introduced in Congress – A Federal Backstop for Business Interruption and Event Cancellation Losses
- North Carolina Considering COVID-19 Workers’ Compensation Expansion for Frontline and Essential Workers